Medicinal Marijuana: Offering a New Hope for Severe Epilepsy

Marijuana has always been a prickly topic, with science continuously researching its benefits and at the same time being labelled a banned substance. However, new breakthrough after another have continuously been unearthed regarding its beneficial effects, keeping it in the limelight.

The relation between marijuana and epilepsy has been a long one. Medicinal marijuana is often prescribed to patients suffering from epilepsy, as many people and even renowned doctors claim that it contains quite the potential to treat epilepsy.

However, there have been medically sanctioned trials conducted to put this myth to the test, but the initial results suggest marijuana magic may be more circumstantial rather than scientific. Even so, some researchers are sticking to their guns and believe the medicinal potential of the green weed is worth studying further.

Fortunately, their labor has born fruition as a new clinical trial has proven that the effects of marijuana may be limited to a smaller population, but it still packs its medicinal ability. In the experiment the researchers utilized a liquefied form of medicinal marijuana and tested it on individuals who had severe epilepsy and were not responding well to other forms of treatments.

For patients who are not responding well to other forms of medicines and treatments, this is promising news. Marijuana offers painless, if not enjoyable relief from pain and combined with its medicinal property (which is still under research), it can ease the burden of conventional medication for complex cases such as epilepsy.

Even though the research is in its initial phases, the results are in favor of marijuana this time. This has brought more interest in it and has galvanized different researches into marijuana. If successful, this will pave way for a host of new treatments for decades to come.

For the studies, researchers selected 213 participants with age groups from adults to young children. The test group was afflicted with 12 varying sorts of epilepsy including a type which affects mental functionality. The individuals were administered with Cannabidiol present in marijuana, which itself is not addictive and neither gets people high, but is known to contain some medicinal properties. The study was not placebo controlled as the participants were aware what was being given to them.

The study continued for 12 weeks during which the number of participants dropped to 137. Surprisingly, the remaining participants reported a 54 percent decrease in number of seizures while Participants suffering from Dravet Syndrome, which is characterized by convulsive seizures, diarrhea, drowsiness and sleepiness reported the same percentage of reduction in seizures.

With research still underway, many people are intently waiting and hoping for good news. The research conclusions will be delivered at the American Academy of Neurology’s 67th Annual Meeting. We all hope Positive news will stimulate even greater research in this topic and allow conventional application of marijuana based medicines.

Add a Comment

Your email address will not be published. Required fields are marked *